These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 21277962)
1. Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP. Miyazaki T; Aso Y; Yoshioka S; Kawanishi T Int J Pharm; 2011 Apr; 407(1-2):111-8. PubMed ID: 21277962 [TBL] [Abstract][Full Text] [Related]
2. Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature. Miyazaki T; Yoshioka S; Aso Y; Kawanishi T Int J Pharm; 2007 May; 336(1):191-5. PubMed ID: 17184940 [TBL] [Abstract][Full Text] [Related]
3. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder. Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911 [TBL] [Abstract][Full Text] [Related]
4. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy. Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133 [TBL] [Abstract][Full Text] [Related]
5. Preparation of a solid dispersion of felodipine using a solvent wetting method. Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of amorphous itraconazole stabilization in polymer solid dispersions: role of molecular mobility. Bhardwaj SP; Arora KK; Kwong E; Templeton A; Clas SD; Suryanarayanan R Mol Pharm; 2014 Nov; 11(11):4228-37. PubMed ID: 25325389 [TBL] [Abstract][Full Text] [Related]
7. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64. Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228 [TBL] [Abstract][Full Text] [Related]
8. The stability of solid dispersions of felodipine in polyvinylpyrrolidone characterized by nanothermal analysis. Zhang J; Bunker M; Parker A; Madden-Smith CE; Patel N; Roberts CJ Int J Pharm; 2011 Jul; 414(1-2):210-7. PubMed ID: 21627985 [TBL] [Abstract][Full Text] [Related]
9. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Konno H; Taylor LS Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180 [TBL] [Abstract][Full Text] [Related]
10. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers. Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419 [TBL] [Abstract][Full Text] [Related]
11. Characterization and stability of solid dispersions based on PEG/polymer blends. Bley H; Fussnegger B; Bodmeier R Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875 [TBL] [Abstract][Full Text] [Related]
12. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective. Dukeck R; Sieger P; Karmwar P Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913 [TBL] [Abstract][Full Text] [Related]
13. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Konno H; Handa T; Alonzo DE; Taylor LS Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of 19F-NMR for assessing the molecular mobility of flufenamic acid in solid dispersions. Aso Y; Yoshioka S; Miyazaki T; Kawanishi T Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):61-4. PubMed ID: 19122317 [TBL] [Abstract][Full Text] [Related]
15. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels. Sun DD; Ju TC; Lee PI Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548 [TBL] [Abstract][Full Text] [Related]
16. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. Konno H; Taylor LS J Pharm Sci; 2006 Dec; 95(12):2692-705. PubMed ID: 16892209 [TBL] [Abstract][Full Text] [Related]
17. Moisture Sorption by Polymeric Excipients Commonly Used in Amorphous Solid Dispersions and its Effect on Glass Transition Temperature: II. Cellulosic Polymers. Patel NG; Banella S; Serajuddin ATM J Pharm Sci; 2022 Nov; 111(11):3114-3129. PubMed ID: 35921915 [TBL] [Abstract][Full Text] [Related]
18. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Rumondor AC; Marsac PJ; Stanford LA; Taylor LS Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917 [TBL] [Abstract][Full Text] [Related]
19. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib. Xie T; Taylor LS J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Tanno F; Nishiyama Y; Kokubo H; Obara S Drug Dev Ind Pharm; 2004 Jan; 30(1):9-17. PubMed ID: 15000425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]